Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Profit After Tax (2019 - 2023)

Historic Profit After Tax for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$46.7 million.

  • ADC Therapeutics' Profit After Tax rose 767.07% to -$46.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$146.3 million, marking a year-over-year increase of 2159.31%. This contributed to the annual value of $4.7 billion for FY2022, which is 527.6% up from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Profit After Tax is -$46.7 million, which was up 767.07% from -$48.9 million recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Profit After Tax registered a high of $4.7 billion during Q1 2022, and its lowest value of -$126.6 million during Q2 2020.
  • Its 5-year average for Profit After Tax is $484.6 million, with a median of -$35285.0 in 2019.
  • Data for ADC Therapeutics' Profit After Tax shows a peak YoY increase of 931652.73% (in 2022) and a maximum YoY decrease of 269695798.07% (in 2022) over the last 5 years.
  • Quarter analysis of 5 years shows ADC Therapeutics' Profit After Tax stood at -$35285.0 in 2019, then crashed by 57510.88% to -$20.3 million in 2020, then soared by 99.83% to -$34381.0 in 2021, then increased by 29.74% to -$24157.0 in 2022, then crashed by 193326.34% to -$46.7 million in 2023.
  • Its last three reported values are -$46.7 million in Q3 2023, -$48.9 million for Q2 2023, and $3.9 billion during Q1 2023.